Kaufman Kenneth R, Coluccio Melissa, Sivaraaman Kartik, Campeas Miriam
, MD, FRCPsych, DLFAPA, FAES, Departments of Psychiatry, Neurology and Anesthesiology, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
, BS, Department of Psychiatry, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
BJPsych Open. 2017 Oct 4;3(5):249-253. doi: 10.1192/bjpo.bp.117.005538. eCollection 2017 Sep.
Optimal anti-epileptic drug (AED) treatment maximises therapeutic response and minimises adverse effects (AEs). Key to therapeutic AED treatment is adherence. Non-adherence is often related to severity of AEs. Frequently, patients do not spontaneously report, and clinicians do not specifically query, critical AEs that lead to non-adherence, including sexual dysfunction. Sexual dysfunction prevalence in patients with epilepsy ranges from 40 to 70%, often related to AEDs, epilepsy or mood states. This case reports lamotrigine-induced sexual dysfunction leading to periodic non-adherence.
To report lamotrigine-induced sexual dysfunction leading to periodic lamotrigine non-adherence in the context of multiple comorbidities and concurrent antidepressant and antihypertensive pharmacotherapy.
Case analysis with PubMed literature review.
A 56-year-old male patient with major depression, panic disorder without agoraphobia and post-traumatic stress disorder was well-controlled with escitalopram 20 mg bid, mirtazapine 22.5 mg qhs and alprazolam 1 mg tid prn. Comorbid conditions included complex partial seizures, psychogenic non-epileptic seizures (PNES), hypertension, gastroesophageal reflux disease and hydrocephalus with patent ventriculoperitoneal shunt that were effectively treated with lamotrigine 100 mg tid, enalapril 20 mg qam and lansoprazole 30 mg qam. He acknowledged non-adherence with lamotrigine secondary to sexual dysfunction. With lamotrigine 300 mg total daily dose, he described no libido with impotence/anejaculation/anorgasmia. When off lamotrigine for 48 h, he described becoming libidinous with decreased erectile dysfunction but persistent anejaculation/anorgasmia. When off lamotrigine for 72 h to maximise sexual functioning, he developed auras. Family confirmed patient's consistent monthly non-adherence for 2-3 days during the past year.
Sexual dysfunction is a key AE leading to AED non-adherence. This case describes dose-dependent lamotrigine-induced sexual dysfunction with episodic non-adherence for 12 months. Patient/clinician education regarding AED-induced sexual dysfunction is warranted as are routine sexual histories to ensure adherence.
No financial interests. K.R.K. is Editor of ; he took no part in the peer-review of this work.
© The Royal College of Psychiatrists 2017. This is an open access article distributed under the terms of the Creative Commons Non-Commercial, No Derivatives (CC BY-NC-ND) license.
最佳抗癫痫药物(AED)治疗可使治疗反应最大化,并将不良反应(AE)降至最低。AED治疗的关键在于依从性。不依从性通常与AE的严重程度有关。患者往往不会主动报告,临床医生也不会专门询问导致不依从的关键AE,包括性功能障碍。癫痫患者性功能障碍的患病率在40%至70%之间,通常与AED、癫痫或情绪状态有关。本病例报告了拉莫三嗪引起的性功能障碍导致周期性不依从。
报告在多种合并症以及同时使用抗抑郁药和抗高血压药物治疗的情况下,拉莫三嗪引起的性功能障碍导致周期性拉莫三嗪不依从。
进行病例分析并检索PubMed文献。
一名56岁男性患者,患有重度抑郁症、无广场恐惧症的惊恐障碍和创伤后应激障碍,服用艾司西酞普兰20 mg每日两次、米氮平22.5 mg每晚一次以及阿普唑仑1 mg每日三次按需服用,病情得到良好控制。合并症包括复杂部分性发作、心因性非癫痫性发作(PNES)、高血压、胃食管反流病和脑积水伴脑室腹腔分流管通畅,分别用拉莫三嗪100 mg每日三次、依那普利20 mg每日上午一次以及兰索拉唑30 mg每日上午一次进行有效治疗。他承认因性功能障碍而未坚持服用拉莫三嗪。当拉莫三嗪总日剂量为300 mg时,他描述自己没有性欲,伴有阳痿/不射精/性高潮缺失。停用拉莫三嗪48小时后,他描述自己性欲增强,勃起功能障碍有所减轻,但仍持续存在不射精/性高潮缺失。为了使性功能最大化而停用拉莫三嗪72小时后,他出现了先兆症状。家人证实患者在过去一年中每月持续有2至3天不依从治疗。
性功能障碍是导致AED不依从的关键AE。本病例描述了剂量依赖性拉莫三嗪引起的性功能障碍,伴有12个月的间歇性不依从。有必要对患者/临床医生进行关于AED引起性功能障碍的教育,并进行常规性病史询问以确保依从性。
无经济利益。K.R.K.是《》的编辑;他未参与本作品的同行评审。
©皇家精神科医学院2017年。本文是一篇开放获取文章,根据知识共享非商业性、无衍生作品(CC BY - NC - ND)许可协议分发。